LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Search

Elanco Animal Health Inc

Închisă

SectorSănătate

21.48

Rezumat

Modificarea prețului

24h

Curent

Minim

21.42

Maxim

21.6

Indicatori cheie

By Trading Economics

Venit

-56M

11M

Vânzări

48M

1.2B

P/E

Medie Sector

25.966

77.256

Marjă de profit

0.886

Angajați

9,000

EBITDA

3M

264M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+10.89% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

4.4B

11B

Deschiderea anterioară

21.48

Închiderea anterioară

21.48

Sentimentul știrilor

By Acuity

30%

70%

74 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Elanco Animal Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 mai 2025, 11:29 UTC

Achiziții, Fuziuni, Preluări

Elanco Sells Non-Core Asset to Blackstone for $295 Million

5 mai 2025, 11:14 UTC

Achiziții, Fuziuni, Preluări

Elanco Sells Non-Core Asset to Blackstone for $295 Mln

5 mai 2025, 10:50 UTC

Achiziții, Fuziuni, Preluări

Elanco Animal Health: Monetization of This Non-Core Asset Will Be Used to Accelerate Debt Reduction >ELAN

5 mai 2025, 10:49 UTC

Achiziții, Fuziuni, Preluări

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone for $295M

Comparație

Modificare preț

Elanco Animal Health Inc Așteptări

Obiectiv de preț

By TipRanks

10.89% sus

Prognoză pe 12 luni

Medie 23.83 USD  10.89%

Maxim 27 USD

Minim 18 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruElanco Animal Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

8 ratings

7

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

9.77 / N/ASuport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Weak Bullish Evidence

Sentiment

By Acuity

74 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
help-icon Live chat